Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study

scientific article

Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJ.G6356
P932PMC publication ID4216099
P698PubMed publication ID25361731
P5875ResearchGate publication ID267745809

P50authorGraham ColditzQ5592728
Bernard A. RosnerQ76570651
Susan E. HankinsonQ76570836
Janet Rich-EdwardsQ87271575
Stacey MissmerQ91277908
Karin B. MichelsQ92307907
Brittany M CharltonQ92367994
Frank E. SpeizerQ28114643
P2860cites workProgestins and breast cancerQ56030177
Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatmentQ57560086
Phasic contraceptive pills and functional ovarian cystsQ68159359
Functional ovarian cysts and oral contraceptives. Negative association confirmed surgically. A cooperative studyQ68773369
Breast cancer and combined oral contraceptives: results from a multinational study. The WHO Collaborative Study of Neoplasia and Steroid ContraceptivesQ68926745
Patterns of oral contraceptive use in the United StatesQ69805159
Test of the National Death IndexQ71344931
Ovarian function during low-dose oral contraceptive useQ71732197
Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception StudyQ72464161
Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study GroupQ72692127
Mortality and the pill. Wrong conclusions drawn, againQ84204046
Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception StudyQ24629702
The Royal College of General Practitioners' Oral Contraception Study: some recent observationsQ28269824
Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast CancerQ28295346
A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States)Q28304748
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controlsQ31147531
Ischemic stroke risk with oral contraceptives: A meta-analysisQ33953321
Factors affecting mortality in a large cohort study with special reference to oral contraceptive use.Q34130935
Oral contraceptive use and breast cancer: a prospective study of young womenQ34134707
Mortality in relation to oral contraceptive use and cigarette smokingQ34217740
Maternal deaths averted by contraceptive use: an analysis of 172 countriesQ34287361
Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studiesQ34305820
Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health StudyQ34339315
Oral contraceptives and moodQ34390323
Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception studyQ34486389
Production and actions of estrogensQ34513002
Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysisQ34573557
To what extent do oral contraceptives influence mood and affect?Q34750705
Risk factors for mortality in the nurses' health study: a competing risks analysisQ35017437
Mortality among oral contraceptive users: 20 year follow up of women in a cohort studyQ35719637
Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United StatesQ37463944
Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysisQ37469729
Hormonal contraception and risk of endometrial cancer: a systematic reviewQ37792640
The state of hormonal contraception today: established and emerging noncontraceptive health benefitsQ37941079
Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US womenQ38503066
Oral contraceptives use and the risk of myocardial infarction: a meta-analysisQ39130555
Contraceptive use and associations with intimate partner violence among a population-based sample of New Zealand womenQ39834589
The Nurses' Health StudyQ40382857
A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular developmentQ41111787
Oral contraceptive type and functional ovarian cystsQ41114193
Oral contraception and health.Q43136786
Oral contraceptives in the United States: trends in content and potencyQ45276872
Hormonal contraception and mental health: results of a population-based studyQ45372447
Use of contraception in the United States: 1982-2008Q46869329
Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian womenQ46921099
Test of the National Death Index and Equifax Nationwide Death Search.Q52363384
P407language of work or nameEnglishQ1860
P304page(s)g6356
P577publication date2014-10-31
P1433published inThe BMJQ546003
P1476titleOral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study
P478volume349

Reverse relations

cites work (P2860)
Q33641708A Review of hormone-based therapies to treat adult acne vulgaris in women
Q91258014A prospective clinical cohort study of women at increased risk for endometrial cancer
Q36991832A prospective cohort study of endometriosis and subsequent risk of infertility.
Q92621113A prospective investigation of oral contraceptive use and breast cancer mortality: findings from the Swedish women's lifestyle and health cohort
Q55713330Benefits of reversible contraception.
Q37704116Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Q92127319Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats
Q64098384Continuous Use of Combined Hormonal Contraceptive and the Effect on Blood Coagulation Factors in Female Capuchin Monkeys ()
Q64078095Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk
Q33729336Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk
Q52985664Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study.
Q90497405Female reproductive factors and risk of external causes of death among women: The Japan Public Health Center-based Prospective Study (JPHC Study)
Q92723013Hierarchies of evidence applied to lifestyle Medicine (HEALM): introduction of a strength-of-evidence approach based on a methodological systematic review
Q38562815Impact of progesterone on stem/progenitor cells in the human breast
Q92070408Long-acting reversible contraception: A route to reproductive justice or injustice
Q38579398Meta-analysis of oral contraceptive use and risks of all-cause and cause-specific death.
Q33631557Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?
Q100755293Oral contraceptive use and risk of suicidal behavior among young women
Q96961742Pille, Depression und Suizid – ein Statement aus kinder- und jugendpsychiatrischer und gynäkologischer Sicht
Q38619701Real-world research and the role of observational data in the field of gynaecology - a practical review
Q35826696Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study

Search more.